StockData
LENSAR, Inc. logo

LENSAR, Inc. (LNSR) company profile

LNSRNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 8/3022% below fair value
$4.85−0.06 (-1.22%)

Close on Nov 18, 2026Market cap $59.59MP/E –Yield –

About Lensar

Surgical & Medical Instruments & Apparatus, SIC 3841

LENSAR, Inc. is a commercial-stage medical device company that develops, designs, and markets advanced femtosecond laser systems. Its primary offerings include the LENSAR Laser System and the next-generation ALLY Robotic Cataract Laser System, which integrate proprietary technologies such as advanced imaging and procedural planning to support ophthalmic procedures. The company’s systems are designed for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its customer base consists of ophthalmic cataract surgeons, practices, and ambulatory surgery centers.

The company operates its principal executive offices in Orlando, Florida. Its product offerings are commercially available across the United States and the European Union, with additional regulatory clearances obtained in international markets including India and Taiwan. Distribution and commercialization efforts occur domestically through direct sales initiatives as well as internationally through global distributor networks.

Summary of the business section of Lensar's latest annual report, written by StockData.

Company profile

Company

Legal name
LENSAR, Inc.
Headquarters
Orlando, FL
Address
2800 Discovery Drive, Suite 100 32826
Phone
(888) 536-7271
Website
lensar.com
Employees
150, Dec 31, 2025
Industry
Surgical & Medical Instruments & Apparatus
Incorporated in
Delaware
Fiscal year ends
December 31
Auditor
PricewaterhouseCoopers LLP, Raleigh, North Carolina

Stock & identifiers

Ticker
LNSR
Exchange
Nasdaq
IPO date
Oct 2, 2020
Shares outstanding
12M, Jul 31, 2026
Public float
$113.30M, Jun 30, 2025
Filer category
Non-accelerated filer<br>Smaller reporting company
SEC CIK
1320350
CUSIP
52634L108
ISIN
US52634L1089
FIGI
BBG00X8RZBR7
Share class FIGI
BBG00X8RZCL1
EIN
32-0125724

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Nicholas T. CurtisChief Executive Officer, Director1,122,758
Michael A. RossiInterim CFO–
Alan B. ConnaughtonChief Operating Officer389,173
Kendra WongPrincipal Accounting Officer56,481
Thomas R. Staab IiChief Financial Officer174,609
Gary M. WinerDirector109,804
Richard L. Lindstrom MdDirector263,831
Todd B. HammerDirector1,156,675
William J. Link PhdDirector568,062
Aimee S. WeisnerDirector110,368
Thomas B. EllisDirector1,156,675
Elizabeth G. O'FarrellDirector67,368

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2025$2.34M$3.19M$928.74K$331–
FY2024$1.58M$3.00M$916.44K$255–

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Executive compensation, fiscal 2025

Summary compensation table from the latest proxy statement

ExecutiveSalaryStock awardsIncentive payOtherTotalvs. prior year
Nicholas T. Curtis
Chief Executive Officer
$582.76K$1.31M$439.67K$15.30K$2.34M+49%
Alan B. Connaughton
Chief Operating Officer
$437.07K$381.28K$241.82K$15.30K$1.08M+5%
Thomas R. Staab, II
Former Chief Financial Officer
$412.88K$130.72K$207.67K$30.73K$782.00K-3%

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

Employees

Headcount reported in annual reports

“As of December 31, 2025, we had approximately 150 employees that support our manufacturing, research and development, commercial and administrative functions.”

Corporate history

Events identified from SEC filings

DateEventDetails
May 19, 2025Merger voteDefinitive merger proxy statement
Aug 26, 2020Spin-offRegistration as a new public company (Form 10), e.g. spin-off
Jun 16, 2006Name changeName changed from LaserSoft Vision Inc to LensAR Inc

See a number that looks wrong?